Ring, J., Worm, M., Wollenberg, A. et al. (35 more authors) (2021) Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35 (6). e362-e365. ISSN 0926-9959
Abstract
Since the introduction of active vaccination against SARS‐CoV‐2 infection, there has been a debate about the risk of developing severe allergic or anaphylactic reactions among individuals with a history of allergy. Indeed, rare cases of severe allergic reactions have been reported in the United Kingdom and North America. By February 2021 a rate of 4,5 severe allergic reactions occurred among 1 million patients vaccinated with the mRNA‐based COVID‐19 vaccines, which is higher than the generally expected rate of severe allergic reactions to vaccinations of around 1 in 1 million.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2021 European Academy of Dermatology and Venereology. This is an author-produced version of a paper subsequently published in Journal of the European Academy of Dermatology and Venereology. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Covid-19 vaccine; allergy; anaphylaxis; atopic dermatitis; practical management |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Sheffield Teaching Hospitals |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 24 Mar 2021 11:03 |
Last Modified: | 10 Feb 2022 12:03 |
Status: | Published |
Publisher: | Wiley |
Refereed: | Yes |
Identification Number: | 10.1111/jdv.17237 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:172500 |